Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,374 across all filing types
Latest filing 2022-06-13 Capital/Financing Update
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2022 SECOND TRANCHE OF MEDIUM-TERM NOTES
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the results of the issuance of the 2022 second tranche of medium-term notes by Yankuang Energy Group Company Limited. It details the issuance amount, terms, interest rate, and underwriters. The document is relatively short (3203 characters) and serves as a formal announcement of a financing activity rather than a full financial report or detailed analysis. It does not contain comprehensive financial statements or management discussion. Therefore, it fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2022-06-13 English
NOTIFICATION LETTER
Report Publication Announcement Classification · 95% confidence The document is a notification letter from Yankuang Energy Group Company Limited dated 10 June 2022. It informs shareholders about the availability of the 2021 Annual General Meeting and Class Meeting circulars (corporate communications) on the company's and HKEXnews websites. It also includes a Change Request Form for shareholders to select their preferred language and means of receiving future corporate communications. The document explicitly states that corporate communications include directors' reports, annual accounts with auditors' reports, interim reports, notices of meetings, circulars, and proxy forms. However, this document itself is not the actual annual report or AGM materials but a notification about their availability and instructions on how to receive them. The document length is 9274 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the "Menu vs Meal" rule, this document is a Report Publication Announcement (RPA) rather than the actual Annual Report or AGM Information.
2022-06-10 English
Special Dividend for the Year Ended 31 December 2021(Updated)
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Special Dividend for the Year Ended 31 December 2021 (Updated)' and contains detailed information about the dividend type, amount, dates related to shareholders' approval, ex-dividend date, record date, book close period, and payment date. It also includes information about the share registrar and withholding tax. The document is an announcement regarding the dividend amount and related dates, not a full financial report or annual report. The length is 3546 characters, which is relatively short and consistent with a dividend announcement. Therefore, this document fits the category of Notice of Dividend Amount (DIV).
2022-06-10 English
Final Dividend for the Year Ended 31 December 2021(Updated)
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Final Dividend for the Year Ended 31 December 2021 (Updated)' and contains detailed information about the dividend declared, including dividend amount, ex-dividend date, record date, book close period, and payment date. It also mentions the shareholders' approval date and other dividend-related details. The document is relatively short (3545 characters) and is an announcement of dividend details rather than a full financial report or annual report. Therefore, it fits the category of a Notice of Dividend Amount (DIV).
2022-06-10 English
the consent letter from Donvex Capital Limited
Regulatory Filings Classification · 95% confidence The document is a placeholder message from the Hong Kong Exchanges and Clearing Limited stating that the requested document has been removed by the issuer. Since it does not contain any substantive financial or corporate information and serves as a system-generated notice regarding a missing filing, it falls under the general regulatory announcement category.
2022-06-10 English
the Bulk Commodities Sale and Purchase Agreement
Regulatory Filings Classification · 95% confidence The document is a placeholder message from the Hong Kong Exchanges and Clearing Limited stating that the requested document has been removed by the issuer. Since it does not contain any substantive financial or corporate information and serves as a system-generated notice regarding a missing filing, it falls under the general regulatory announcement category.
2022-06-10 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.